Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · · USDFahodi Score BUY Long-term (Investment)
73
/ 100
Technical
100
Trend & RS
91
Momentum
94
Fundamental
78
Macro
23
Liquidity
74
| Component | Score | Weight |
|---|---|---|
| Technical | 100.0 | 10% |
| Trend & RS | 91.1 | 10% |
| Momentum | 94.4 | 5% |
| Fundamental | 77.8 | 40% |
| Macro | 23.3 | 15% |
| Liquidity | 73.8 | 20% |
Trade Setup
| Entry | 902.90 |
| Stop Loss | 839.28 (7.0%) |
| Target 1 (1:1) | 966.52 (+7.0%) |
| Target 2 (2:1) | 1030.14 (+14.1%) |
| ATR(14) | 31.81 (3.5%) |
| Risk per Share | 63.62 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 71.8 | +0.87 | |
| Momentum | 85.8 | +1.43 | |
| Quality | 69.5 | +0.78 | |
| Composite | 75.7 | ||
Quality Scores
Piotroski F-Score
7
/9 —
Strong
✓
✓
✗
✗
✓
✓
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 20.0 | 22.0 | Inline |
| P/B Ratio | 2.7 | 4.0 | Below |
| Dividend Yield | 42.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Intrinsic Value (DCF) Significantly Undervalued
Intrinsic Value
1410.05
vs
Market Price
902.90
Upside
+56.2%
| Margin of Safety | +36.0% |
| Stage 1 PV (5yr FCF) | 28,765,304,328 |
| Terminal Value PV | 117,101,421,611 |
| Total Enterprise Value | 145,866,725,939 |
Assumptions
| Base FCF | 3,743,984,856 |
| Growth Rate (5yr) | 25.0% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
47.64%
Full Kelly
23.82%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 73/100. Estimated win rate 62%, avg win 9.4%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
4
Bullish Signals
0
Bearish Signals
62.93
RSI(14)
40.6646
MACD
Relative Strength (RS) IMPROVING
77
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | ↑ RISING (+20.2% vs SPY 3M) |
| RS vs Sector | INLINE (Healthcare) |
| RS New High | No (2d since high) |
| Sector Outperformance | +2.3% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 62.93 | NEUTRAL |
| Macd | 40.6646 | BULLISH |
| Ma Cross | 802.45 / 740.44 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 1.55x | HIGH |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 991.73 |
| Bollinger Upper | 968.2 |
| SMA(200) | 740.44 |
| SMA(50) | 802.45 |
| SMA(20) | 829.96 |
| Current Price | 902.90 |
| Bollinger Lower | 691.71 |
| 52-Week Low | 591.52 |
| ATR(14) | 31.81 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
64%
Sign of Strength
Buying Climax
Acc: 0.0 |
Dist: 2.0 |
Markup: 3.5 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-10-30 | Normal | 3.17x | Normal bar — no special VSA pattern |
| 2026-11-02 | Normal | 1.83x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 1.32x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.54x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.55x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 894.17 | Above Kijun |
| Kijun-sen (26) | 856.88 | Base line |
| Senkou A | 875.52 | Leading span A |
| Senkou B | 856.88 | Leading span B |
| Cloud | 856.88 – 875.52 | Bullish (Green) |
| Price vs Cloud | 902.90 | Above Cloud |
| Chikou Span | 734.81 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 691.71 – 968.2 | KC: 784.24 – 875.67
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 739.34
Anchor: 2026-06-02 (52w Low)
ABOVE AVWAP
+22.1%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/REGN
Valuation
| Metric | Value |
|---|---|
| Market Cap | 93.40B |
| P/E (TTM) | 19.96 |
| Forward P/E | N/A |
| P/B | 2.70 |
| EPS | 45.24 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 36.3% |
| Profit Margin | 28.5% |
| ROE | 14.9% |
| Debt/Equity | 8.08 |
| Current Ratio | 3.35 |
| Dividend Yield | 42.0% |
| Payout Ratio | N/A |
| Beta | 0.10 |
Trading Data
902.90
Open
902.90
Day High
902.90
Day Low
1.40M
Volume (1.8x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)